Skip to content

TURKAPNE - The Turkish Sleep Apnea Database: A National, Multicenter, Observational, Prospective Cohort Study

TURKAPNE - The Turkish Sleep Apnea Database: A National, Multicenter, Observational, Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02784977
Acronym
TURKAPNE
Enrollment
10000
Registered
2016-05-27
Start date
2017-10-03
Completion date
2027-12-31
Last updated
2022-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

Primary aim of the TURKAPNE (The Turkish Sleep Apnea Database) study is to generate a cross-sectional nationwide database to define clinical and polysomnographic characteristics of the sleep apnea patients in Turkey. Associations of phenotypes of sleep apnea patients with metabolic and cardiovascular diseases as well as risk for traffic accidents will be explored as secondary aims. Impact of treatment of sleep apnea on metabolic and cardiovascular complications as well as compliance with positive airway pressure treatment will be further explored longitudinally.

Detailed description

All subjects undergoing sleep study for suspicion of obstructive sleep apnea will be registered in a web-based national database regarding: * Anthropometric data, educational status, driving licence, * Smoking and alcohol use * Comorbidities, and drug use * Questionnaires, excessive daytime sleepiness * Polygraphic and polysomnographic findings * Blood pressure measurements * If taken, blood glucose, lipids and other biochemical markers * If measured, lung function test results * If measured, echocardiography findings * Follow-up data regarding treatment modality and compliance

Interventions

Treatment of OSA with PAP

DEVICEIntraoral device (IOD)

Treatment of OSA with IOD

PROCEDUREUvuloplasty

Uvuloplasty

OTHERConservative treatment

No active intervention

Sponsors

Ege University School of Medicine, Izmir, Turkey
CollaboratorUNKNOWN
Dokuz Eylul University
CollaboratorOTHER
Diskapi Yildirim Beyazit Education and Research Hospital
CollaboratorOTHER_GOV
Uludag University
CollaboratorOTHER
Dicle University School of Medicine, Diyarbakir, Turkey
CollaboratorUNKNOWN
Namik Kemal University School of Medicine, Tekirdag
CollaboratorOTHER
Suleyman Demirel University School of Medicine, Isparta, Turkey
CollaboratorUNKNOWN
Istanbul University - Cerrahpasa
CollaboratorOTHER
Pamukkale University School of Medicine, Denizli, Turkey
CollaboratorUNKNOWN
Trakya University School of Medicine, Edirne, Turkey
CollaboratorUNKNOWN
Afyon Kocatepe University School of Medicine, Afyon, Turkey
CollaboratorUNKNOWN
Hitit University School of Medicine, Corum, Turkey
CollaboratorUNKNOWN
Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital
CollaboratorOTHER
Kocaeli Education and Research Hospital, Kocaeli, Turkey
CollaboratorUNKNOWN
Baskent University Ankara Hospital
CollaboratorOTHER
Marmara University
CollaboratorOTHER
Koç University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Consecutive adult patients undergoing sleep study for suspicion of obstructive sleep apnea * Ability to read and speak * Signed informed consent.

Exclusion criteria

* subjects who use positive airway pressure * subjects with limited life expectancy due to advanced renal disease or uncontrolled malignancies * subjects with alcohol dependency

Design outcomes

Primary

MeasureTime frameDescription
Metabolic and cardiovascular diseases in obstructive sleep apnea phenotypesUp to three yearsThe association of sleep apnea severity indices such as Apnea-Hypopnea Index and Oxygen Desaturation Index during Rapid Eye Movement (REM) sleep and non-REM sleep with self-reported diabetes mellitus and cardiovascular diseases will be explored.

Secondary

MeasureTime frameDescription
Sex differences in obstructive sleep apnea phenotypesUp to three yearsPossible sex differences in REM-dependent sleep apnea, positional sleep apnea and its association with metabolic and cardiovascular diseases will be explored
Adherence to positive airway pressure treatment in obstructive sleep apneaThrough study completion, an average of 7 yearsPredictors of adherence to positive airway pressure treatment (defined as device usage at least 4 hours of night during at least 70% of study period) in obstructive sleep apnea
Incidence of cardiovascular diseases and mortalityThrough study completion, an average of 7 yearsNumber of patients who have died or developed cardiovascular diseases

Countries

Turkey (Türkiye)

Contacts

Primary ContactYüksel Peker, Prof
yukselpeker26@gmail.com+905443483866
Backup ContactBaran Balcan, Assoc. Prof
drbaranbalcan@gmail.com+905304142308

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026